Phase II study of disitamab vedotin (RC48) in combination with tislelizumab and bevacizumab in patients (Pts) with HER2 alterations locally advanced or metastatic NSCLC: Primary analysis results of ...
Emerging treatments for advanced cholangiocarcinoma: Addressing the knowledge gap. Background: HCC is a leading cause of cancer-related deaths worldwide. LEN is now a first-line treatment option for ...
Dilemma 2: Do I Need Mechanical Circulatory Support? Case Presentation (LM with LVSD) Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...
Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...
SAN FRANCISCO--(BUSINESS WIRE)--PicnicHealth, a leading patient-centered healthcare evidence generation company, today announced the launch of a new study portal to facilitate faster, more accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results